Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: A case-cohort study and meta-analyses

Vascular Health and Risk Management

Volumn 4, Issue 2, 2008, Pages 427-436

  Zafarmand, Mohammad Hadi ^a,c   van der Schouw, Yvonne T ^a   Grobbee, Diederick E ^a   de Leeuw, Peter W ^b   Bots, Michiel L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genetics; Myocardial infarction; Polymorphism; Population based; PPARG gene; Risk factors

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NETHERLANDS; RISK FACTOR; RISK REDUCTION;

AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MODELS, GENETIC; MYOCARDIAL INFARCTION; NETHERLANDS; POLYMORPHISM, GENETIC; PPAR GAMMA; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 44049101537     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Al Shali KZ, House AA, Hanley AJ, et al. 2004. Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke, 35:2036-40.
2. Altshuler D, Hirschhorn JN, Klannemark M, et al. 2000. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet, 26:76-80.
3. Bluher M, Klemm I, Gerike T, et al. 2002. Lack of association between peroxisome proliferator-activated receptor-gamma-2 gene variants and the occurrence of coronary heart disease in patients with diabetes mellitus. Eur J Endocrinol, 146:545-51.
4. Cheng S, Grow MA, Pallaud C, et al. 1999. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res, 9:936-49.
5. Deeb SS, Fajas L, Nemoto M, et al. 1998. A Pro12Ala substitution in PPAR-gamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet, 20:284-7.
6. Doney AS, Fischer B, Leese G, et al. 2004. Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study. Arterioscler Thromb Vasc Biol, 24:2403-7.
7. Higgins JP, Thompson SG, Deeks JJ, et al. 2003. Measuring inconsistency in meta-analyses. BMJ, 327:557-60.
8. Knouff C, Auwerx J. 2004. Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev, 25:899-918.
9. Lau J, Ioannidis JP, Schmid CH. 1997. Quantitative synthesis in systematic reviews. Ann Intern Med, 127:820-6.
10. Lee BC, Lee HJ, Chung JH. 2006. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes. Neurosci Lett, 410:141-5.
11. Li L, Cheng LX, Nsenga R, et al. 2006. Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population. Clin Cardiol, 29:300-4.
12. Masud S, Ye S. 2003. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet, 40:773-80.
13. Meirhaeghe A, Fajas L, Helbecque N, et al. 2000. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord, 24:195-9.
14. Memisoglu A, Hu FB, Hankinson SE, et al. 2003. Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes. Diabetes Care, 26:2915-17.
15. Ostgren CJ, Lindblad U, Melander O, et al. 2003. Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: skaraborg hypertension and diabetes project. J Hypertens, 21:1657-62.
16. Peters JL, Sutton AJ, Jones DR, e al. 2006. Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295:676-80
17. Pischon T, Pai JK, Manson JE, et al. 2005. Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women. Arterioscler Thromb Vasc Biol, 25:1654-8.
18. Prentice RL. 1986. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika, 73:1-11.
19. Ridker PM, Cook NR, Cheng S, et al. 2003. Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol, 23:859-63.
20. Schiffrin EL, Amiri F, Benkirane K, et al. 2003. Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension. Hypertension, 42:664-8.
21. Smith GD, Ebrahim S. 2004. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol, 33:30-42.
22. Temelkova-Kurktschiev T, Hanefeld M, Chinetti G, et al. 2004. Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis. J Clin Endocrinol Metab, 89:4238-42.
23. Tobin MD, Braund PS, Burton PR, et al. 2004. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J, 25:459-67.
24. Trikalinos TA, Salanti G, Khoury MJ, et al. 2006. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol, 163:300-9.
25. Vos HL, Doggen CJM, Rosendaal FR. 2000. Effect of the PPAR gamma2 Pro12Ala polymorphism on the risk of myocardial infarction. Blood, 96:62B.
26. Youssef J, Badr M. 2004. Role of peroxisome proliferator-activated receptors in inflammation control. J Biomed Biotechnol, 2004:156-166.
27. 3-adrenergic receptor gene (ADRB3) and coronary heart disease: a case-cohort study and meta-analysis. J Intern Med, In Press.
28. Zee RYL, Cook NR, Cheng S, et al. 2006. Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis. J Thromb Haemost, 4:341-8.